Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 14.3%Low 4 · 57.1%Moderate 0 · 0%High 2 · 28.6%

Summary of findings table ‐ Progestogens vs GnRH agonist

Live birth or ongoing pregnancy · assisted reproduction technology cycles

Summary of findings table ‐ Progestagen showed no clear difference in live birth or ongoing pregnancy compared with gnRH agonist (low certainty).

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
OR 0.94 [0.58, 1.53]
1 study · 260 participants
Low

Summary of findings table ‐ Progestogens vs GnRH agonist

Oocyte pick‐up cancellation · assisted reproduction technology cycles

Summary of findings table ‐ Progestagen showed no clear difference in oocyte pick‐up cancellation compared with gnRH agonist (low certainty).

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
OR 1.36 [0.46, 4.02]
1 study · 260 participants
Low

Summary of findings table ‐ Progestogens vs GnRH agonist

Clinical pregnancy · assisted reproduction technology cycles

Summary of findings table ‐ Progestagen showed no clear difference in clinical Pregnancy compared with gnRH agonist (low certainty).

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
OR 0.88 [0.54, 1.44]
1 study · 260 participants
Low

Summary of findings table ‐ Progestogens vs GnRH agonist

Miscarriage · assisted reproduction technology cycles

Summary of findings table ‐ Progestagen showed no clear difference in miscarriage compared with gnRH agonist (low certainty).

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
OR 0.49 [0.12, 2]
1 study · 260 participants
Low

Summary of findings table ‐ Progestogens vs GnRH agonist

MII oocytes · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
High

Summary of findings table ‐ Progestogens vs GnRH agonist

Total dose of gonadotropins · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
High

Summary of findings table ‐ Progestogens vs GnRH agonist

Moderate or severe OHSS · assisted reproduction technology cycles

It is very uncertain whether summary of findings table ‐ Progestagen changes moderate or severe OHSS compared with gnRH agonist (very low certainty).

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
OR 0.14 [0.01, 2.73]
1 study · 260 participants
Very low